Pharmaceutical stability testing helps researchers understand how a drug product or material changes over time under defined environmental and storage conditions. A well-designed stability program can reveal changes that affect quality, performance, safety, and the ability of a product to meet established specifications throughout its intended shelf life. These studies require careful planning because temperature, humidity, light exposure, packaging, formulation characteristics, and analytical variability can all influence the resulting data.
Following established best practices gives pharmaceutical organizations stronger information for development decisions, regulatory activities, investigations, and ongoing quality programs. Particle Technology Labs shares our best practices for pharmaceutical stability testing and answers a few commonly asked questions in our lab.
Define Clear Stability Testing Objectives
Every effective stability program starts with a clearly defined scientific objective rather than a collection of tests chosen without sufficient context. Teams should determine which material characteristics they need to monitor, what changes could affect product quality, and which analytical techniques can detect those changes with appropriate sensitivity. These considerations may differ considerably between a suspension, emulsion, injectable formulation, powder, biologic product, or another pharmaceutical material. Establishing the purpose early also helps laboratories develop a testing strategy that produces useful information instead of generating data that lacks meaningful context.
Study objectives should connect directly to the product’s formulation, dosage form, manufacturing process, packaging system, and anticipated storage conditions. Researchers may need to investigate physical instability, chemical degradation, aggregation, particle formation, changes in particle size, or other characteristics that influence product performance. The analytical plan should focus on attributes that can meaningfully demonstrate whether the material remains consistent over the relevant period.
Establish Meaningful Testing Conditions
Storage conditions play a central role in pharmaceutical stability testing because environmental exposure can influence how quickly and in what ways a material changes. Researchers should select appropriate temperature, humidity, and light conditions according to the purpose of the study, applicable regulatory expectations, and characteristics of the pharmaceutical product.
Long-term studies can characterize product behavior under intended storage conditions, while accelerated conditions can provide additional insight into potential degradation pathways or physical changes. It’s best for teams to document and control these conditions carefully so that they can interpret results within the correct experimental context.
Choose Stability-Indicating Analytical Methods
A stability study can only provide useful information when its analytical methods respond appropriately to relevant changes in the material. Laboratories should evaluate method suitability, sensitivity, precision, range, and robustness in relation to the attribute under investigation. A method that performs well for initial characterization may not necessarily provide enough sensitivity to identify subtle changes during a stability program. Scientists should therefore select techniques according to the material and the specific stability question rather than relying on a standard analytical package for every sample.
Particle characterization can play an important role when physical changes may affect pharmaceutical quality or performance. Depending on the formulation, researchers may need to investigate particle size distributions, aggregation, outlier particles, or changes within an otherwise uniform population. For example, single particle optical sensing offers high sensitivity for detecting outliers in emulsions, proteins, aggregates, and other expected uniform populations.
Monitor Particle Populations Carefully
Changes in particle populations can provide valuable evidence about the physical stability of certain pharmaceutical formulations. An increase in larger particles, aggregates, or unusual outliers may indicate changes that deserve additional investigation, even when the bulk population appears relatively consistent. A light obscuration particle count test can support this type of evaluation when the sample characteristics and study objectives align with the technique. Scientists should interpret particle data alongside formulation knowledge and other analytical findings rather than treating a single measurement as a complete explanation of product stability.
SPOS combines light extinction and light scattering to evaluate particles across its detection range. During analysis, a dilute particle suspension passes through uniform illumination from a laser diode, allowing the instrument to measure individual particles as they cross the detection region. Larger particles create measurable reductions in transmitted light, while smaller particles generate scattered light that reaches a separate detector.
Plan Sample Quantity Before the Study Begins
Stability programs often require multiple time points, storage conditions, analytical methods, replicates, and potential follow-up investigations, so sample quantity can become an important practical constraint. Planning quantities before placing materials on stability can prevent shortages later in the program and gives the laboratory enough material to perform representative analyses.
For applicable PTL testing, preferred quantities can vary according to material type, transparency, dispersion requirements, and instrument configuration. Discussing limited sample availability before testing begins can help analysts determine whether smaller quantities can still support the intended analytical objective.
Several practical considerations can guide sample planning for particle characterization, including:
- PTL generally recommends approximately 50 mL to 250 mL for applicable liquid materials.
- More transparent materials may benefit from larger sample volumes.
- Some materials may allow volumes as low as approximately 25 mL after consultation with PTL.
- Dry materials require at least 200 mg, although 1 to 2 grams provides a preferred working quantity.
- Limited samples may require adjustments based on material properties, dispersion methods, and instrument configuration.
Work With an Experienced Particle Characterization Laboratory
Successful stability testing depends on more than storing samples and collecting measurements at scheduled intervals. Pharmaceutical teams need clear objectives, appropriate analytical methods, controlled preparation procedures, sufficient sample quantities, consistent execution, and scientifically sound interpretation throughout the study.
When particle behavior represents a critical quality consideration, sensitive characterization methods can reveal changes that broader measurements may not fully capture. Partnering with Particle Technology Labs gives organizations access to specialized expertise that can turn stability data into useful scientific insight and better-informed development decisions. To learn more about our best practices for pharmaceutical stability testing, contact a member of our team or submit a sample.
Frequently Asked Questions About Pharmaceutical Stability Testing
Why Is Pharmaceutical Stability Testing Important?
We find that pharmaceutical stability testing helps organizations understand whether important product characteristics change during storage and over time. These studies can support shelf-life decisions, formulation development, quality programs, regulatory activities, and investigations into product performance.
How Can Particle Characterization Support a Stability Study?
Particle characterization can identify changes in particle size, aggregation, outlier populations, or other physical properties that may develop during storage. The most appropriate analytical technique depends on the formulation, particle characteristics, concentration, sample medium, and scientific question.
When Should a Company Consult PTL About Stability Testing?
Organizations benefit from early consultation when particle characteristics may influence product quality, performance, or stability. Early discussions give PTL an opportunity to evaluate sample properties, analytical goals, available quantities, dispersion requirements, and suitable instrument configurations before testing begins. This approach can prove especially valuable for challenging formulations or programs with limited material.